QR-Code

HSF1 is involved in immunotherapeutic response through regulating APOJ/STAT3-mediated PD-L1 expression in hepatocellular carcinoma

Hepatocellular cancer (HCC) is a serious illness with high prevalence and mortality throughout the whole world. For advanced HCC, immunotherapy is somewhat impactful and encouraging. Nevertheless, a substantial proportion of patients with advanced HCC are still unable to achieve a durable response,...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Hongxia Cheng, Sikai Wang, Aidan Huang, Jing Ma, Dongmei Gao, Miaomiao Li, Huaping Chen, Kun Guo
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis Group 2023-12-01
Schriftenreihe:Cancer Biology & Therapy
Schlagworte:
hepatocellular carcinoma
immunotherapy
hsf1
pd-l1
apoj
jak/stat3
Online-Zugang:http://dx.doi.org/10.1080/15384047.2022.2156242
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge